Savvy Updates 6/13/22: Dexcom vs. Abbott, CREATE Trial: DIY Insulin Delivery System Safe, Effective, Gluroo App

Dexcom and Abbott’s fight over glucose monitoring patents intensifies in Europe was posted by Amy Sandys for, 20 May 2022.

Dexcom and Abbott are currently going head-to-head over twelve separate patents covering their respective glucose monitoring devices (continuous glucose monitoring, or CGMs). The dispute spans the UK, Germany and the US, although it is likely that other European jurisdictions are involved.  With around one in 14 people in the UK alone living with diabetes, the market is vast.

Leave a Reply

Your email address will not be published.